Home
About
Overview
Sharing Data
ORCID
Help
History (27)
The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice.
Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells.
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
Unsupported off-label chemotherapy in metastatic colon cancer.
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy. J Cancer Surviv. 2023 02; 17(1):27-39.
View in:
PubMed
subject areas
Antineoplastic Agents
Cancer Survivors
Cisplatin
Hearing Loss
Humans
Hypercholesterolemia
Male
Prevalence
Risk Factors
Testicular Neoplasms
Tinnitus
authors with profiles
Mary Dolan